USD 11.18
(-6.83%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 5.17 Billion CNY | -9.68% |
2023 | 5.17 Billion CNY | 11.83% |
2022 | 5.12 Billion CNY | 46.21% |
2021 | 3.5 Billion CNY | 54.23% |
2020 | 2.27 Billion CNY | 59.59% |
2019 | 1.42 Billion CNY | 82.17% |
2018 | 782 Million CNY | 103.02% |
2017 | 385.17 Million CNY | 54.85% |
2016 | 248.73 Million CNY | 68.99% |
2015 | 147.19 Million CNY | 211.81% |
2014 | 47.2 Million CNY | -47.26% |
2013 | 89.51 Million CNY | 17.0% |
2012 | 76.5 Million CNY | 31.39% |
2011 | 58.23 Million CNY | -23.8% |
2010 | 76.41 Million CNY | -40.68% |
2009 | 128.82 Million CNY | -1.81% |
2008 | 131.19 Million CNY | -5.48% |
2007 | 138.8 Million CNY | -12.73% |
2006 | 159.04 Million CNY | 27.02% |
2005 | 125.2 Million CNY | 182.34% |
2004 | 44.34 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 FY | 5.17 Billion CNY | -9.68% |
2024 Q2 | 365.43 Million USD | 0.0% |
2024 Q4 | 368.05 Million USD | 0.0% |
2023 Q2 | 346.12 Million USD | 0.0% |
2023 FY | 5.73 Billion CNY | 11.83% |
2023 Q4 | 489.36 Million USD | 0.0% |
2022 Q4 | 430.82 Million USD | 0.0% |
2022 FY | 5.12 Billion CNY | 46.21% |
2022 Q2 | 380.84 Million USD | 0.0% |
2021 Q2 | 232.93 Million USD | 0.0% |
2021 Q4 | 295.25 Million USD | 0.0% |
2021 FY | 3.5 Billion CNY | 54.23% |
2020 Q2 | 82.67 Million USD | 0.0% |
2020 FY | 2.27 Billion CNY | 59.59% |
2020 Q4 | 88.97 Million USD | 0.0% |
2019 FY | 1.42 Billion CNY | 82.17% |
2018 FY | 782 Million CNY | 103.02% |
2017 FY | 385.17 Million CNY | 54.85% |
2016 FY | 248.73 Million CNY | 68.99% |
2015 FY | 147.19 Million CNY | 211.81% |
2014 FY | 47.2 Million CNY | -47.26% |
2013 FY | 89.51 Million CNY | 17.0% |
2012 FY | 76.5 Million CNY | 31.39% |
2011 FY | 58.23 Million CNY | -23.8% |
2010 FY | 76.41 Million CNY | -40.68% |
2009 FY | 128.82 Million CNY | -1.81% |
2008 FY | 131.19 Million CNY | -5.48% |
2007 FY | 138.8 Million CNY | -12.73% |
2006 FY | 159.04 Million CNY | 27.02% |
2005 FY | 125.2 Million CNY | 182.34% |
2004 FY | 44.34 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alternative Energy Partners, Inc. | 3437.19 USD | -150643827.161% |
Allstar Health Brands, Inc. | 215.74 Thousand USD | -2399895.365% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 55.24 Million USD | -9273.198% |
Café Serendipity Holdings, Inc. | 1.43 Million USD | -360406.444% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | 47.57 Thousand USD | -10884739.184% |
HealthWarehouse.com, Inc. | 13.79 Million USD | -37433.12% |
LIGAND PHARMACEUTICAL INC | 78.2 Million USD | -6520.955% |
MedGen, Inc. | 16.59 USD | -31211078863.231% |
Omni Health, Inc. | 1.14 Million USD | -451321.153% |
Oxford Investments Holdings Inc. | 373.76 Thousand USD | -1385255.347% |
Pineapple, Inc. | 452.94 Thousand USD | -1143059.48% |
ScripsAmerica, Inc. | 31.4 Million USD | -16387.878% |